Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 4/20 | 0.40 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.40 |
| ▸ | BCHE | P06276 | 5/20 | 0.38 |
| ▸ | BACE1 | P56817 | 3/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.36 |
| ▸ | CYP26B1 | Q9NR63 | 1/20 | 0.36 |
| ▸ | KIF11 | P52732 | 1/20 | 0.36 |
| ▸ | CCR9 | P51686 | 1/20 | 0.36 |
| ▸ | RXRA | P19793 | 1/20 | 0.36 |
| ▸ | RXRB | P28702 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21177003 | 0.83 | CYP1A2 (0.37) | HDAC8TAAR1CYP1A2CYP2C19 | |
| SCHEMBL14805471 | 0.83 | HDAC4 (0.44) | HDAC4HDAC2HDAC8ACHEBCHE | |
| SCHEMBL16167473 | 0.82 | TAAR1 (0.40) | HDAC4HDAC2HDAC8ACHETAAR1 | |
| SCHEMBL66607 | 0.82 | TAAR1 (0.61) | HDAC8TAAR1 | |
| SCHEMBL27871630 | 0.81 | GABRA1 (0.38) | CYP1A2RXRARXRBTP53TSHR | |
| SCHEMBL19258592 | 0.80 | MEN1 (0.43) | TAAR1 | |
| SCHEMBL910853 | 0.79 | MGLL (0.41) | CYP1A2TP53 | |
| Formaldehyde SCHEMBL28263667 | 0.79 | TAAR1 (0.57) | HDAC8TAAR1 | |
| SCHEMBL1864936 | 0.77 | TP53 (0.52) | TP53TSHRNR1H4 | |
| SCHEMBL66122 | 0.77 | TP53 (0.52) | TP53TSHRNR1H4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| US-20100256421-A1 | Propanal Production Methods | O'LAUGHLIN INDUSTRIES, CO. LTD. (CN) | 2010-10-07 | — | — | US | claimed |
| EP-2233556-A1 | Isomeric mixture of meta and para tertio-butylphenyl propanal and production thereof | O'Laughlin Industries, Co. Ltd. (HK) | 2010-09-29 | — | — | EP | claimed |
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | disclosed |
| EP-2657218-B1 | Novel Fragrance Compounds | GIVAUDAN SA (CH) | 2017-07-26 | — | — | EP | disclosed |
| EP-2657218-B1 | Novel Fragrance Compounds | GIVAUDAN SA (CH) | 2017-07-26 | — | — | EP | disclosed |
| US-20170152252-A1 | TRPV1 Vanilloid Receptor Antagonists With A Bicyclic Portion | SERENTRIX, LLC | 2017-06-01 | — | — | US | disclosed |
| US-20160289199-A1 | TRPV1 Vanilloid Receptor Antagonists With A Bicyclic Portion | SERENTRIX LLC (US) | 2016-10-06 | — | — | US | disclosed |
| CN-101535232-B | Fragrance compound | GIVAUDAN S.A. (CH) | 2016-05-11 | — | — | CN | disclosed |
| US-9216975-B2 | TRPV1 vanilloid receptor antagonists with a bicyclic portion | Serentrix, LLC. (US) | 2015-12-22 | — | — | US | disclosed |
| CN-102574757-B | M-or to substituted-phenyl alkanol method is prepared by alkylation | BASF SE (DE) | 2015-12-02 | — | — | CN | disclosed |
| EP-2233556-A1 | Isomeric mixture of meta and para tertio-butylphenyl propanal and production thereof | O'Laughlin Industries, Co. Ltd. (HK) | 2010-09-29 | — | — | EP | disclosed |
| EP-2233556-A1 | Isomeric mixture of meta and para tertio-butylphenyl propanal and production thereof | O'Laughlin Industries, Co. Ltd. (HK) | 2010-09-29 | — | — | EP | disclosed |
| US-20100069287-A1 | Novel Fragrance Compounds | GIVAUDAN NEDERLAND SERVICES B.V. (CH) | 2010-03-18 | — | — | US | disclosed |
| US-20100069287-A1 | Novel Fragrance Compounds | GIVAUDAN NEDERLAND SERVICES B.V. (CH) | 2010-03-18 | — | — | US | disclosed |
| US-20100069287-A1 | Novel Fragrance Compounds | GIVAUDAN NEDERLAND SERVICES B.V. (CH) | 2010-03-18 | — | — | US | disclosed |
| CN-101535232-A | Novel fragrance compounds | QUEST INT SERV BV (NL) | 2009-09-16 | — | — | CN | disclosed |
| EP-2077986-A1 | NOVEL FRAGRANCE COMPOUNDS | Givaudan Nederland Services B.V. (NL) | 2009-07-15 | — | — | EP | disclosed |
| WO-2008053148-A1 | NOVEL FRAGRANCE COMPOUNDS | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2008-05-08 | — | — | WO | disclosed |
| WO-2008053148-A1 | NOVEL FRAGRANCE COMPOUNDS | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2008-05-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100256421-A1 | Propanal Production Methods | ALDH2, ALDH1A3, TERT | HDAC4 3034/4885HDAC2 1907/4885HDAC8 2771/4885 |
| US-20170152252-A1 | TRPV1 Vanilloid Receptor Antagonists With A Bicyclic Portion | TRPV1, TRPV5, TRPV3 | HDAC4 2460/4885HDAC2 966/4885HDAC8 2817/4885 |
| US-20160289199-A1 | TRPV1 Vanilloid Receptor Antagonists With A Bicyclic Portion | TRPV1, TRPV5, TRPV3 | HDAC4 2460/4885HDAC2 966/4885HDAC8 2817/4885 |
| US-20100069287-A1 | Novel Fragrance Compounds | C1S, C5, FADS1 | HDAC4 2432/4885HDAC2 2178/4885HDAC8 891/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.